|
|
|
|
| Primary Industry: |
| Biotechnology |
 |
|
SIC Industry Code:
|
|
NAICS Industry Code:
|
|
Thomson Financial Business Description:
| The Group's principal activity is providing outsourced research and development to the pharmaceutical industry and is a distributor for goods used in the life science industry. The Group provides a range of products and services that are used by its clients in the pharmaceutical industry to enhance their drug discovery productivity. These solutions enable clients to make better-informed decisions during drug development, through enhanced understanding of the role of gene and protein targets in disease progression and by being able to predict and eliminate drug candidates which might otherwise fail in late-stage development due to issues of toxicity or poor efficacy. The key products are biorepository tissues, Cytomyx RNA, RT-PCK cDNA panels, tissue section and tissue micro arrays. The Group's clients include, AstraZeneca, H Lee Moffitt Cancer Center and Research Institute, Paradigm Therapeutics and Invitrogen Corp. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Cytomyx Holdings plc
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
